CLSK
CleanSpark, Inc.
There isn't enough reported data to score CLSK yet.
MSFT
Microsoft Corporation
MSFT's fundamentals are strong and it looks cheap: trading at 27x earnings, below its usual 34x. Analysts expect strong earnings growth.
CLSK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Unavailable | |
| Weak |
CLSK's revenue is currently healthy, but its profitability and balance sheet are weak. There isn't enough data to rate its cash flow.
MSFT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Healthy | |
| Strong |
MSFT's revenue, profitability, cash flow and balance sheet are all currently healthy.
CLSK PE Valuation
CLSK has no meaningful PE right now: it lost money over the past year.
MSFT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 25x | $523 | — |
| Cheap | 27x | $525 | +0.4% |
| Current | 27x | $523 | — |
| Fair | 34x | $652 | +25% |
| Expensive | 37x | $711 | +36% |
Historical ranges are pointers, not guarantees.
MSFT's PE is in its cheap range at 27x. If earnings grow as analysts expect, today's price would be 25x next year's earnings.
CLSK Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Stable | |
| Strongly weakening | |
| Limited | |
| Low |
Analysts expect CLSK's losses to grow, with revenue holding steady. However, they disagree widely on these estimates.
MSFT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Moderate | |
| High |
MSFT has the edge over CLSK on the outlook, with more favorable earnings and revenue expectations.
CLSK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$3.80 | -614% |
| Q1 2026 | -$2.09 | -$1.02 |
| Q4 2025 | -$1.06 | -$1.06 |
| Q3 2025 | $1.12 | +$1.81 |
| Q2 2023 | -$1.77 | -$1.25 |
| Q1 2023 | -$2.36 | -$2.06 |
| Q4 2022 | -$2.13 | -$2.05 |
| Q3 2022 | -$1.35 | -$0.60 |
CLSK has swung to a loss: it lost $3.80 per share over the past year, after a profit the year before.
MSFT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $20.79 | +8.6% |
| Q3 2026 | $19.15 | +36% |
| Q2 2026 | $17.95 | +32% |
| Q1 2026 | $16.80 | +30% |
| Q4 2025 | $15.99 | +29% |
| Q3 2025 | $14.06 | +16% |
| Q2 2025 | $13.64 | +16% |
| Q1 2025 | $12.93 | +12% |
| Q4 2024 | $12.41 | +12% |
MSFT has the edge over CLSK on earnings quality, reporting a profit while its opponent remains loss making.
CLSK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2024 | $89.3M | +70% |
| Q2 2024 | $104.1M | +129% |
| Q1 2024 | $111.8M | +163% |
| Q4 2023 | $73.8M | +165% |
| Q3 2023 | $52.5M | +101% |
| Q2 2023 | $45.5M | +47% |
| Q1 2023 | $42.5M | +2.2% |
| Q4 2022 | $27.8M | -33% |
CLSK has the stronger quarterly revenue trend. Revenue is up 70% for CLSK versus up 19% for MSFT.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2024 | -73% | +58 points |
| Q2 2024 | -239% | -205 points |
| Q1 2024 | 123% | +164 points |
| Q4 2023 | 39% | +143 points |
| Q3 2023 | -132% | +24 points |
| Q2 2023 | -34% | +14 points |
| Q1 2023 | -41% | -49 points |
| Q4 2022 | -104% | -115 points |
CLSK's operating margin was −73% last quarter, up 58 points from the same quarter a year ago.
MSFT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $92.3B | +19% |
| Q2 2026 | $90B | +18% |
| Q1 2026 | $82.9B | +18% |
| Q4 2025 | $81.3B | +17% |
| Q3 2025 | $77.7B | +18% |
| Q2 2025 | $76.4B | +18% |
| Q1 2025 | $70.1B | +13% |
| Q4 2024 | $69.6B | +12% |
MSFT's revenue has grown year over year every quarter since late 2020: $92.3B last quarter, up 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 50% | +0.9 points |
| Q2 2026 | 45% | +0.2 points |
| Q1 2026 | 46% | +0.7 points |
| Q4 2025 | 47% | +1.6 points |
| Q3 2025 | 49% | +2.3 points |
| Q2 2025 | 45% | +1.8 points |
| Q1 2025 | 46% | +1.1 points |
| Q4 2024 | 45% | +1.9 points |
MSFT's operating margin was 50% last quarter, up 0.9 points from the same quarter a year ago, near the top of its range since 2019.
CLSK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$118.4M | -$8.5M |
| Q1 2026 | -$173.4M | -$61.1M |
| Q4 2025 | -$198.1M | -$78.6M |
| Q2 2025 | -$109.9M | -$31.5M |
| Q1 2025 | -$112.3M | -$53.9M |
| Q4 2024 | -$119.5M | -$51.9M |
| Q3 2024 | -$95.5M | -$32.7M |
| Q2 2024 | -$78.3M | -$59.1M |
MSFT has the stronger cash trend. Its trailing FCF is down 7.4% versus its history, compared with CLSK at down 283%.
MSFT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $18.6B | -27% |
| Q2 2026 | $19.6B | -23% |
| Q1 2026 | $15.8B | -22% |
| Q4 2025 | $5.9B | -9.3% |
| Q3 2025 | $25.7B | +33% |
| Q2 2025 | $25.6B | +9.6% |
| Q1 2025 | $20.3B | -3.2% |
| Q4 2024 | $6.5B | -29% |
MSFT's free cash flow has been positive every quarter for seven years: $60B over the past year, down 23% from the year before.
CLSK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -4.1% | -11M shares |
| 1 year | -21% | -68.8M shares |
| 3 years | +287% | +190M shares |
| 5 years | +4901% | +252M shares |
CLSK has the edge over MSFT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $460M |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $145M |
CLSK spent $460M buying back its own shares over the past year.
MSFT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -7M shares |
| 1 year | -0.3% | -20M shares |
| 3 years | -0.2% | -16M shares |
| 5 years | -1.6% | -121M shares |
| Available history | -3.2% | -245M shares |
MSFT has 7.4B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.4B |
| Q2 2026 | $4.6B |
| Q1 2026 | $4.6B |
| Q4 2025 | $7.4B |
| Q3 2025 | $5.7B |
| Q2 2025 | $4.5B |
| Q1 2025 | $4.8B |
| Q4 2024 | $5B |
MSFT spent $21B buying back its own shares over the past year, up 5.2% from the year before.
CLSK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 150.4x | High |
| Q4 2025 | 7.4x | High |
| Q3 2025 | 0.9x | Very low |
| Q2 2025 | 1.1x | Healthy |
| Q4 2024 | 1.6x | Healthy |
| Q3 2024 | -20.5x | Net Cash |
| Q2 2024 | -14.8x | Net Cash |
| Q1 2024 | -1.4x | Net Cash |
CLSK's net debt is more than 20 years of its operating earnings (EBITDA), up from 1.6 years a year ago.
MSFT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | 0.1x | Very low |
MSFT's net debt is less than a year of its operating earnings (EBITDA).
CLSK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 8.2 | Oversold |
CLSK's weekly RSI is 34 (neutral) and its Stochastic is 8 (oversold).
MSFT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.1 | Neutral |
| Stochastic | 68.0 | Neutral |
MSFT's weekly RSI is 62 (neutral) and its Stochastic is 68 (neutral).
CLSK PE vs Technology Sector
| Metric | CLSK | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
CLSK has no meaningful PE right now: it lost money over the past year.
MSFT PE vs Technology Sector
| Metric | MSFT | Sector median | Relative |
|---|---|---|---|
| PE | 27x | 28x | 2% below |
| PE % | 16 | 35 | 19 pts below |
MSFT is trading at 27x earnings, in line with the Technology sector's median of 28x.
CLSK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.27 | 26% below |
| 20 week MA | $11.5 | 40% below |
| 50 week MA | $12.0 | 43% below |
| 100 week MA | $11.5 | 41% below |
| 200 week MA | $10.5 | 35% below |
CLSK is in a downtrend: it's below all five of its weekly moving averages, and 35% below its 200-week average.
MSFT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $524.7 | 0.3% below |
| 20 week MA | $484.8 | 7.9% above |
| 50 week MA | $446.9 | 17% above |
| 100 week MA | $453.8 | 15% above |
| 200 week MA | $411.5 | 27% above |
MSFT has the edge over CLSK on trend strength, trading above more of its moving averages.
CLSK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.2 | $24.9 | +54% |
| 2021 | $24.9 | $11.9 | -52% |
| 2022 | $11.9 | $1.97 | -83% |
| 2023 | $1.97 | $11.0 | +460% |
| 2024 | $11.0 | $9.78 | -11% |
| 2025 | $9.78 | $10.9 | +12% |
| 2026 YTD | $10.9 | $6.84 | -37% |
CLSK's yearly returns have swung widely, from +460% in 2023 to −83% in 2022. It's down 37% so far in 2026.
MSFT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $159.0 | $222.8 | +40% |
| 2021 | $222.8 | $334.7 | +50% |
| 2022 | $334.7 | $238.7 | -29% |
| 2023 | $238.7 | $376.0 | +58% |
| 2024 | $376.0 | $430.5 | +14% |
| 2025 | $430.5 | $487.7 | +13% |
| 2026 YTD | $487.7 | $523.0 | +7.2% |
MSFT has the edge over CLSK on returns for 2026, with the stronger performance.